ESPACOX, 50 MG/ML ORAL SUSPENSION FOR PIGS

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Buy It Now

Active ingredient:

TOLTRAZURIL

Available from:

Industrial Veterinaria, S.A.

ATC code:

QP51AJ01

INN (International Name):

TOLTRAZURIL

Dosage:

50 Mg/Ml

Pharmaceutical form:

Oral Suspension

Prescription type:

POM

Therapeutic group:

Porcine

Therapeutic area:

Toltrazuril

Therapeutic indications:

Coccidiostats

Authorization status:

Authorised

Authorization date:

2014-07-04

Summary of Product characteristics

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Espacox, 50 mg/ml oral suspension for pigs.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Toltrazuril
50 mg
EXCIPIENTS:
Sodium benzoate (E211)
2.1 mg
Sodium propionate (E281)
2.1 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Oral suspension.
White or yellowish suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs (Piglets, 3 - 5 days old).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the prevention of clinical signs of coccidiosis in neonatal piglets (3 - 5 days old) on farms with a confirmed history
of coccidiosis caused by _Isospora suis_.
4.3 CONTRAINDICATIONS
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
It is recommended to treat all animals in a pen.
Hygienic measures may reduce the risk of coccidiosis. It is therefore, recommended to improve concomitantly the
hygienic conditions in the concerned facility, particularly dryness and cleanliness.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 04/07/2014_
_CRN 7014615_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
To alter the course of an established clinical coccidial infection, in individual animals already showing signs of
diarrhoea, additional supportive therapy may be required.
As with any antiparasiticide, frequent and repeated use of antiprotozoals from the same class may lead to the
development of resistance.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
In case of accidental inge
                                
                                Read the complete document
                                
                            

Search alerts related to this product